OG
The startup operates a preclinical drug investment and development platform that licenses transformational medicines while streamlining the licensing process and expediting patent approvals. This approach reduces the overall cost of drug discovery and accelerates the transition of therapies into clinical trials, facilitating faster access to treatments for patients.
Updated 3 months ago
Funding
$30M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates a preclinical drug investment and development platform that licenses transformational medicines while streamlining the licensing process and expediting patent approvals. This approach reduces the overall cost of drug discovery and accelerates the transition of therapies into clinical trials, facilitating faster access to treatments for patients.